Cargando…
Screening‐based identification of xanthone as a novel NLRP3 inflammasome inhibitor via metabolic reprogramming
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288006/ https://www.ncbi.nlm.nih.gov/pubmed/34323410 http://dx.doi.org/10.1002/ctm2.496 |
_version_ | 1783724015996633088 |
---|---|
author | Cui, Wenyu Chen, Sheng Chi, Zhexu Guo, Xingchen Zhang, Xiaobo Zhong, Yueyang Han, Haijie Yao, Ke |
author_facet | Cui, Wenyu Chen, Sheng Chi, Zhexu Guo, Xingchen Zhang, Xiaobo Zhong, Yueyang Han, Haijie Yao, Ke |
author_sort | Cui, Wenyu |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8288006 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82880062021-07-21 Screening‐based identification of xanthone as a novel NLRP3 inflammasome inhibitor via metabolic reprogramming Cui, Wenyu Chen, Sheng Chi, Zhexu Guo, Xingchen Zhang, Xiaobo Zhong, Yueyang Han, Haijie Yao, Ke Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-07-19 /pmc/articles/PMC8288006/ /pubmed/34323410 http://dx.doi.org/10.1002/ctm2.496 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to Editor Cui, Wenyu Chen, Sheng Chi, Zhexu Guo, Xingchen Zhang, Xiaobo Zhong, Yueyang Han, Haijie Yao, Ke Screening‐based identification of xanthone as a novel NLRP3 inflammasome inhibitor via metabolic reprogramming |
title | Screening‐based identification of xanthone as a novel NLRP3 inflammasome inhibitor via metabolic reprogramming |
title_full | Screening‐based identification of xanthone as a novel NLRP3 inflammasome inhibitor via metabolic reprogramming |
title_fullStr | Screening‐based identification of xanthone as a novel NLRP3 inflammasome inhibitor via metabolic reprogramming |
title_full_unstemmed | Screening‐based identification of xanthone as a novel NLRP3 inflammasome inhibitor via metabolic reprogramming |
title_short | Screening‐based identification of xanthone as a novel NLRP3 inflammasome inhibitor via metabolic reprogramming |
title_sort | screening‐based identification of xanthone as a novel nlrp3 inflammasome inhibitor via metabolic reprogramming |
topic | Letter to Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288006/ https://www.ncbi.nlm.nih.gov/pubmed/34323410 http://dx.doi.org/10.1002/ctm2.496 |
work_keys_str_mv | AT cuiwenyu screeningbasedidentificationofxanthoneasanovelnlrp3inflammasomeinhibitorviametabolicreprogramming AT chensheng screeningbasedidentificationofxanthoneasanovelnlrp3inflammasomeinhibitorviametabolicreprogramming AT chizhexu screeningbasedidentificationofxanthoneasanovelnlrp3inflammasomeinhibitorviametabolicreprogramming AT guoxingchen screeningbasedidentificationofxanthoneasanovelnlrp3inflammasomeinhibitorviametabolicreprogramming AT zhangxiaobo screeningbasedidentificationofxanthoneasanovelnlrp3inflammasomeinhibitorviametabolicreprogramming AT zhongyueyang screeningbasedidentificationofxanthoneasanovelnlrp3inflammasomeinhibitorviametabolicreprogramming AT hanhaijie screeningbasedidentificationofxanthoneasanovelnlrp3inflammasomeinhibitorviametabolicreprogramming AT yaoke screeningbasedidentificationofxanthoneasanovelnlrp3inflammasomeinhibitorviametabolicreprogramming |